Improving cholesterol control after narrowing in brain arteries
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at strategies to improve cholesterol treatment in adults whose brain arteries are narrowed and who have had symptoms. Better cholesterol management may help reduce future problems related to this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have moderate to severe narrowing in brain arteries that has caused symptoms, and you did not have procedures like clot-busting medicine, thrombectomy, or stenting inside the blood vessel.
- Your LDL (“bad cholesterol”) is higher than 70 mg/dL (1.8 mmol/L).
- You are able and willing to have MRI brain scans (often 3T) so the blood vessels can be measured for the study.
- A clinician has told you that a statin (cholesterol-lowering medicine) is recommended for you.
- You can sign the study consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a PCSK9 inhibitor to standard statin therapy can help people with narrowing in brain arteries that hasn't caused symptoms yet. The goal is to see if this combination lowers plaque and prevents future strokes.
This study records outcomes for people with significant narrowing in brain arteries who have treatment using a drug-eluting stent. It may help doctors understand how well this approach works and what risks or benefits to expect.
This study tests two approaches together: a computer-based brain training program and a stronger cholesterol-lowering medicine, to see if they can help improve memory and thinking in people with narrowed brain arteries. You would be randomly assigned to different combinations of the two, and the doctors will monitor your progress.
This study tests two different strengths of cholesterol-lowering medicine (statins) to see which better prevents strokes in people with narrowed arteries inside the brain. It aims to find the safest and most effective level of treatment.
This trial tests whether adding a PCSK9 inhibitor to a statin is better than a statin alone for people with mild-to-moderate narrowing of the carotid artery (the main artery in the neck). It looks at how well these treatments slow plaque buildup and prevent strokes.
This trial tests whether a cholesterol-lowering drug (called a PCSK9 inhibitor) can help people who had a stroke and a procedure to clear a blocked vessel. It aims to see if the drug reduces the risk of another stroke or improves recovery.
Hear when a new Intracranial Artery Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.